Close
4

Promoted Content Promoted Content

X

Company profile for Eurofins CDMO

Client EmailClient Virtual Booth
EUROFINS CDMO
  • Connect with Us...

  • Corporate Presentation

  • Eurofins Advinus Chemistry Services

  • Eurofins Advinus Bioanalytical Services

  • Clinical Development and cGMP Manufacturing Services

  • Solid State Research and Development Services

  • Highly Potent API Capabilities

  • Flow Chemistry Capabilities

  • API Commercialization Services

  • API Commercialization Support Services

  • PYROFREE

  • Sterile Manufacturing FDFs

  • Formulation Development & Manufacturing Non Sterile FDFs

  • Clinical Trial Supply Packaging & Logistics

  • Biologicals Drug Substance & Drug Products

  • Your Drug Development Partner

  • Highly Potent Drug Development from Early Stage

  • Eurofins CDMO Announces Expansion of Drug Product Capabilities in Canada

  • Eurofins Amatsigroup Becomes Eurofins CDMO

  • Eurofins Alphora Becomes Eurofins CDMO

  • API Developmental Services

  • (Bio)Pharmaceutical Development Services

  • All Services

  • Analytical

  • API Manufacturing

  • Drug Product Manufacturing

  • Sales, Marketing, Registration

  • Clinical Trials

  • Packaging

  • API & Drug Product Development

  • High Potent APIs (HPAPI) Manufacturing

PharmaCompass

Virtual Booth Your Drug Development and Manufacturing Partner for Drug Substance (DS)/API and Drug Product for biologics or small molecules.

Eurofins CDMO provides integrated, end-to-end development and manufacturing services for Drug Substance/API and Drug Product manufacturing for biologics and small molecules. We are experts for highly potent compounds, poorly soluble drugs, lyophilisation processes, orphan drugs, paediatric forms. Our services: API/DS Development, Solid State R&D, Preformulation, Formulation Development, GMP Manufacturing, Clinical Packaging and Logistics, CMC Regulatory Support.
Eurofins-CDMO
Eurofins CDMO
France Flag
Country
Country
FRANCE
Address
Address
2 bis, Avenue de Gascogne, 31470 Fontenilles
Telephone
Telephone
33 562 147 314
Contact Info
Others

left grey arrow
right gray arrow
  • Corporate Presentation
  • Eurofins Advinus Chemistry Services
  • Eurofins Advinus Bioanalytical Services
  • Clinical Development and cGMP Manufacturing Services
  • Solid State Research and Development Services
  • Highly Potent API Capabilities
  • Flow Chemistry Capabilities
  • API Commercialization Services
  • API Commercialization Support Services
  • PYROFREE
  • Sterile Manufacturing FDFs
  • Formulation Development & Manufacturing Non Sterile FDFs
  • Clinical Trial Supply Packaging & Logistics
  • Biologicals Drug Substance & Drug Products
  • Your Drug Development Partner
  • Highly Potent Drug Development from Early Stage
  • Eurofins CDMO Announces Expansion of Drug Product Capabilities in Canada
  • Eurofins Amatsigroup Becomes Eurofins CDMO
  • Eurofins Alphora Becomes Eurofins CDMO
  • API Developmental Services
  • (Bio)Pharmaceutical Development Services

https://www.pharmacompass.com/pdf/party/content/eurofins-cdmo-party-content-1605708146.pdf

https://www.pharmacompass.com/pdf/party/content/eurofins-cdmo-party-content-1614583945.pdf

https://www.pharmacompass.com/pdf/party/content/eurofins-cdmo-party-content-1614583847.pdf

https://www.pharmacompass.com/pdf/party/content/eurofins-cdmo-party-content-1614583652.pdf

https://www.pharmacompass.com/pdf/party/content/eurofins-cdmo-party-content-1614583551.pdf

https://www.pharmacompass.com/pdf/party/content/eurofins-cdmo-party-content-1614583451.pdf

https://www.pharmacompass.com/pdf/party/content/eurofins-cdmo-party-content-1614583251.pdf

https://www.pharmacompass.com/pdf/party/content/eurofins-cdmo-party-content-1614583140.pdf

https://www.pharmacompass.com/pdf/party/content/eurofins-cdmo-party-content-1614583076.pdf

https://www.pharmacompass.com/pdf/party/content/eurofins-cdmo-party-content-1605761884.pdf

https://www.pharmacompass.com/pdf/party/content/eurofins-cdmo-party-content-1605762088.pdf

https://www.pharmacompass.com/pdf/party/content/eurofins-cdmo-party-content-1605761130.pdf